Product Name :
Phlorizin
Description:
Apatinib, also known as Rivoceranib, is an orally bioavailable, small-molecule receptor tyrosine kinase inhibitor with potential antiangiogenic and antineoplastic activities. The free-base form is also known as Rivoceranib. Apatinib selectively binds to and inhibits vascular endothelial growth factor receptor 2, which may inhibit VEGF-stimulated endothelial cell migration and proliferation and decrease tumor microvessel density. In addition, this agent mildly inhibits c-Kit and c-SRC tyrosine kinases.
CAS:
60-81-1
Molecular Weight:
436.41
Formula:
C21H24O10
Chemical Name:
1-(2,4-dihydroxy-6-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-3-(4-hydroxyphenyl)propan-1-one
Smiles :
OC[C@H]1O[C@@H](OC2=CC(O)=CC(O)=C2C(=O)CCC2C=CC(O)=CC=2)[C@H](O)[C@@H](O)[C@@H]1O
InChiKey:
IOUVKUPGCMBWBT-QNDFHXLGSA-N
InChi :
InChI=1S/C21H24O10/c22-9-16-18(27)19(28)20(29)21(31-16)30-15-8-12(24)7-14(26)17(15)13(25)6-3-10-1-4-11(23)5-2-10/h1-2,4-5,7-8,16,18-24,26-29H,3,6,9H2/t16-,18-,19+,20-,21-/m1/s1
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.{{3-AP} medchemexpress|{3-AP} DNA/RNA Synthesis|{3-AP} Purity & Documentation|{3-AP} Formula|{3-AP} custom synthesis|{3-AP} Epigenetic Reader Domain}
Shelf Life:
≥360 days if stored properly.{{Ceralasertib} medchemexpress|{Ceralasertib} PI3K/Akt/mTOR|{Ceralasertib} Biological Activity|{Ceralasertib} Purity|{Ceralasertib} supplier|{Ceralasertib} Cancer}
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.PMID:29844565
Additional information:
Apatinib, also known as Rivoceranib, is an orally bioavailable, small-molecule receptor tyrosine kinase inhibitor with potential antiangiogenic and antineoplastic activities. The free-base form is also known as Rivoceranib. Apatinib selectively binds to and inhibits vascular endothelial growth factor receptor 2, which may inhibit VEGF-stimulated endothelial cell migration and proliferation and decrease tumor microvessel density. In addition, this agent mildly inhibits c-Kit and c-SRC tyrosine kinases.|Product information|CAS Number: 60-81-1|Molecular Weight: 436.41|Formula: C21H24O10|Chemical Name: 1-(2,4-dihydroxy-6-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-3-(4-hydroxyphenyl)propan-1-one|Smiles: OC[C@H]1O[C@@H](OC2=CC(O)=CC(O)=C2C(=O)CCC2C=CC(O)=CC=2)[C@H](O)[C@@H](O)[C@@H]1O|InChiKey: IOUVKUPGCMBWBT-QNDFHXLGSA-N|InChi: InChI=1S/C21H24O10/c22-9-16-18(27)19(28)20(29)21(31-16)30-15-8-12(24)7-14(26)17(15)13(25)6-3-10-1-4-11(23)5-2-10/h1-2,4-5,7-8,16,18-24,26-29H,3,6,9H2/t16-,18-,19+,20-,21-/m1/s1|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.|Shelf Life: ≥360 days if stored properly.|Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.|Drug Formulation: To be determined|HS Tariff Code: 382200|Products are for research use only. Not for human use.|
